Latest filing published 19 Nov 2019 for Bellerophon Therapeutics, Inc., €24k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Fabian Tenenbaum: trading record in brief
Fabian Tenenbaum discloses dealings in Bellerophon Therapeutics, Inc. to SEC (Form 4). Between 29 November 2016 and 15 November 2019, the trades on record add up to 7 filings.
On the market, this insider has only ever bought: 2 purchases, €2,664 in total. The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 5 share grants. 2019 to date brings 1 purchase and no sales.
The newest entry dates from 19 November 2019: a share grant of €24k, in Bellerophon Therapeutics, Inc. The last purchase on record was published on 22 May 2019, which is 2,728 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Fabian Tenenbaum
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 76,823 shares@ US$0.3489.9% of flowCommon StockSEC:0001600132-19-000160:0
- 5,000 shares@ US$0.5951.7% of flowCommon StockSEC:0001600132-19-000084:0Canonical exit: 19 Aug 2019 (T+90)
- 224,299 shares0Common StockSEC:0001600132-18-000143:0
- 63,486 shares@ US$2.3782.9% of flowCommon StockSEC:0001600132-18-000076:0
- 55,419 shares0Common StockSEC:0001600132-18-000023:0
- 120,193 shares0Common StockSEC:0001600132-17-000028:0
- 142,857 sharesCommon StockSEC:0001628280-16-021746:0Canonical exit: 27 Feb 2017 (T+90)
7 of 7 declarations